key: cord-0844012-uf5e650y
authors: Ramírez-Rosas, Adriana; Benitez-Guerrero, Tizziani; Corona-Cervantes, Karina; Vélez-Ixta, Juan Manuel; Zavala-Torres, Norma Gabriela; Cuenca-Leija, Jazmin; Martínez-Pichardo, Sarahi; Landero-Montes-de-Oca, María Esther; Bastida-González, Fernando Guadalupe; Zárate-Segura, Paola Berenice; García-Mena, Jaime
title: Study of perinatal transmission of SARS-CoV-2 in a Mexican public hospital
date: 2021-10-08
journal: Int J Infect Dis
DOI: 10.1016/j.ijid.2021.10.006
sha: c1fe2773256c7de40816334525bc74e9a831c94e
doc_id: 844012
cord_uid: uf5e650y

COVID-19 is a viral transmissible disease where limited evidence exists on vertical transmission and prevalence of SARS-CoV-2 during pregnancy, birth, and postnatal period. The objective of this study was to evaluate the possible perinatal transmission of SARS-CoV-2 in mothers and neonates in a sample of Mexican population in a descriptive cross-sectional study. Methods. 133 nasopharyngeal swab samples from mothers, 131 swab samples from neonates, and 140 colostrum samples were obtained, and the presence of SARS-CoV-2 was determined by qPCR. Our results shows that 1 of 8 asymptomatic 38 to 39 weeks pregnant women were positive for the presence of SARS-CoV-2 in nasopharyngeal swabs taken just before delivery; and 1 of 12 nasopharyngeal swabs collected from neonates immediately after delivery without breast feeding were also positive. We also determined that 1 of 47 colostrum/milk samples were positive for the test. In addition, there was not an association of positive results with any collected metadata of mothers or newborns. Conclusions. asymptomatic women carried SARS-CoV-2 virus during delivery, with perinatal transmission of SARS-CoV-2 to newborns. Since neonates were sampled immediately after birth, the detection of positive cases might be due to infection by the virus in-utero.

In December 2019, COVID-19 a novel disease was reported in China and spread around the world in short time, reaching the Americas by the beginning of 2020.

The severe outbreak was declared "public-health emergency of international concern" by 30 January 2020 by the World Health Organization (WHO) (Wu et al., 2020) . This situation led health centers facing a critical infection inflicted by a novel coronavirus identified as the causative pathogen and named SARS-CoV-2 (Karimi- Zarchi et al., 2020) .

The virus SARS-CoV-2 is transmitted by small liquid droplets produced by an infected person during coughing, sneezing, speaking, or breathing (CDC, 2021 , Patel et al., 2020 . A person affected of COVID-19, has fever, cough, dyspnea, and occasionally watery diarrhea as common symptoms. It is estimated that 20 to 30% of the infected patients require mechanical ventilation with 10% probability of dying (Paules et al., 2020) . According to Mexican health authorities, the Mexican population, has higher risk of fatal outcomes in older people or persons with medical comorbidities like hypertension, diabetes and overweight (Secretaria de Salud, 2020).

The first reported COVID-19 case in Mexico was in January 2020 (Suárez et al., 2020) , and according to the Mexican Government, by November 2020 there were 1"011,153 confirmed cases and 99,026 deaths. Similar situations caused the implementation of extraordinary public health measures in several countries to reduce further viral spreading . Nevertheless, despite the health measures taken by authorities, COVID-19 cases continued an upward trend (WHO, 2021) . Nowadays, there are more than 2.5 million confirmed cases and more than 2.4 thousand deaths in Mexico (CONACYT, 2021) . According to official reports, in the Mexican population, there is a higher risk of fatal outcome in older people or persons with medical comorbidities like hypertension, diabetes and overweight (Secretaria de Salud, 2020) .

At population level, one vulnerable group of special interest are pregnant women. Some studies have shown that pregnant women are at greater risk of COVID-19 morbidity and mortality, which increase adverse pregnancy outcomes; however, although results suggest vertical transmission is not frequent, there is no sufficient information about the factors that influence it (Qiao J., 2020; Pluddemann et al., 2021) .

Despite reasonable doubts about the safety of breastfeeding in pandemic times, the beneficial impact of human milk (HM) has been deeply investigated and demonstrated, especially on cases of extremely low birth weight or newborns in neonatal intensive care units (Mercado et al., 2019) . In addition, HM represents the ideal nutrition source, and exclusive breastfeeding is recommended by the WHO at least during the first 6 months after birth (WHO, 2003) . HM has been related to positive effects in the successive phases of life, as it provides protection against the development of obesity, diabetes, and cardiovascular disease, improving neurological development in newborns (Bardanzellu et al., 2019) .

HM also promotes immune system development, by provision of passive immunity via immunoglobulins and other bioactive factors produced in response to viral infections. It is reported that in women previously affected by COVID-19, the human milk contains IgA immunoglobulins, reactive to the receptor binding domain (RBD) of SARS-CoV-2 spike protein, conferring protection to the neonate against the virus (Pace et al., 2021) .

A recent review of thirteen studies testing human milk for the presence of SARS-CoV-2 (Lackey et al., 2020) , reports the presence of virus in one milk sample, and SARS-CoV-2 specific IgG"s in the milk of another study. In China, human milk was analyzed at delivery time in mothers with SARS-CoV-2 positive diagnosis, finding that all milk samples were negative for the virus . In fact, in 2020, WHO determined that no evidence of SARS-CoV-2 transmission was detected on mother's milk with suspected or confirmed COVID-19, therefore it is highly recommended to continue breastfeeding because of the abundant health benefits HM provides to the newborn and which are maintained throughout life (Centeno-Tablante et al., 2021) .

Additional reports describe newborns with positive nasopharyngeal swab after birth, which could be consequence of horizontal transmission by contact with the infected mother or with positive asymptomatic health care personnel at the time of delivery (Auriti et al., 2020) . Another study found no evidence of virus transmission through milk, and it was shown that transmission might have occurred via respiratory droplets from the mother during breastfeeding (Salvatori et al., 2020) . However, limited evidence exists on vertical transmission, prevalence, and clinical features of COVID-19 during pregnancy, birth, and postnatal period in the Mexican population; hence, there is need of evidence for SARS-CoV-2 vertical transmission from mothers to infants. However, it is highly recommended to continue with breastfeeding, as there is evidence that the human milk of infected mothers carries antibodies against SARS-CoV-2 (Mardani and Pourkaveh, 2020) .

There is no conclusive evidence of intrauterine vertical transmission of COVID-19 from infected pregnant mothers to their fetuses (Deniz et al., 2020) ; and infected mothers are at high risk of severe respiratory complications (Karimi et al., 2020) . It was reported that in China, nine neonates born to infected mothers were negative for SARS-CoV2 infection, suggesting there is not intrauterine infection (Cao et al., 2020) . In another case report, detailed studies conducted to test viral vertical transmission, found no vertical transmission caused by intrauterine infection in an asymptomatic COVID-19 pregnant women .

However, in the first reported case of SARS-CoV-2 positive nasopharyngeal swab from a neonate delivered vaginally, both stool and rectal mother swabs were positive for the virus, suggesting neonate infection due to fecal contamination during vaginal delivery (Carosso et al., 2020) . In the same sense, there is a report of SARS-CoV-2 RNA detection in one umbilical cord blood and in two at-term placentas (Fenizia et al., 2020) . SARS CoV-2 infection has been associated with negative perinatal outcomes like fetal distress, premature labor, respiratory distress, thrombocytopenia, abnormal liver function tests, and even death (Zhu et al., 2020; Hosier et al., 2020; Zheng et al., 2020) . In a study in COVID-19 mothers, where the placenta tested positive for SARS CoV-2, and all nasopharyngeal newborn swabs tested negative for the virus, fetal vascular malperfusion was detected in only one of the cases but the infection was associated to thrombosis in fetal circulation (Baergen and Heller, 2020) . In COVID-19, attention has been drawn to the maternal immune response against the virus, which may also negatively affect fetal development due to the symptoms derived from the infection, like high fever, which may damage the fetal neurons, leading to negative neurodegenerative outcomes (Deniz and Tezer, 2020; Forestieri et al., 2020) .

Due to the high number of infections in the Mexican population, it is a constant concern to determine whether childbirth is safe at the time of this pandemic for the potential risk of vertical transmission or not; therefore, it is a priority to quickly establish preventive measures by health systems. The purpose of this work was to explore the possible vertical transmission of the SARS-CoV-2 virus from asymptomatic mother with presence of SARS-CoV-2 RNA to the newborn at the time of delivery.

This was a transversal descriptive cross-sectional study performed in the "Dr.

Gustavo Baz Prada" General Hospital located in the municipality of Ciudad Netzahualcoyotl (19º25'19''N 99º00'53''W) ( Figure 1a ). The study was approved by the Bioethics Committee in Research of the hospital with registry number 208C0101110500T-3157_2020-08. All participants consented to the collection of data and signed the informed consent in accordance with the Declaration of Helsinki.

For this study, 150 samples were collected from July 17th to October 13th, 2020, during the first epidemiological wave ( min, 50° C for 20 min for reverse transcription, 95° C for 5 min enzyme deactivation, and 45 cycles of (95° C for 30 s denaturation, 60° C for 1 min alignment and extension) in the CFX96 Touch System (BIO-RAD). A negative control, a reaction control, and a positive control of non-infectious synthetic DNA contained in the kit (PC SARS CoV2) were used (Corman et al., 2020) .

The viral load of SARS-CoV-2 virus was measured in the samples by RT-ddPCR, using the One-Step RT-ddPCR kit (Cat. 1864021 BIO-RAD, USA). The 2 μL reaction mixture was set up with 5 μL of 4X of Supermix, 2 μL of 25 U/ μL Reverse Transcriptase enzyme, μL of 3 mM DTT, .5 μL of nM primers and probes targeting the N gene of SARS-CoV-2 described by CDC, 3 μL of total RNA, and 8.5

μL of H 2 O. Once mixed, the reactions were transferred to the GCR96 cartridge (Cat. 12006858) and sealed using PX1 PCR plate sealer (Cat. 1814000). The RT-ddPCR cycling protocol was: 50° C for 20 min for reverse transcription, followed of enzyme deactivation at 95° C for 5 min, and 45 cycles of (95° C for 30 s denaturation, 60° C for 1 min for alignment and extension) in the QX ONE Droplet

Digital PCR (ddPCR) System (BIO-RAD) (Corman et al., 2020) .

Data corresponding to samples were filtered and compiled. To assess whether there were significant differences between the positive and negative groups for SARS-CoV-2 RNA content, the Mann-Whitney U test was applied, and p < 0.05 were considered statistically significant. Epidemiological and clinical data were represented as percentages and reported as mean ±Standard Deviation (SD).

Statistical analysis and graphics were evaluated in RStudio v.1.3.1093 program.

For this study, the samples were collected in a public hospital (Fig. 1a) from asymptomatic mothers during a fourteen-week period encompassing the first of the two peaks of the COVID-19 pandemic in the Mexico (Fig 1b) . The nasopharyngeal swabs and human colostrum/milk samples were collected from 150 motherneonate binomial, however, there was a reduction in the number of samples in each category due to low sample quality or incomplete data. As consequence the study was finally made with 133 nasopharyngeal swab samples from mothers, 131 swab samples from neonates, and 140 colostrum/milk samples.

Although the participant women were clinically asymptomatic for COVID-19, upon Figure 1 , Table S1 ). On the other hand, there was not an association of the newborn sex, qualification status, the somatometry, or complications during delivery with the positive results for SARS-CoV-2 ( Table 2) .

Exploration of the presence of SARS-Cov-2 in 140 human colostrum/milk collected from the asymptomatic mothers within the 48h immediately after delivery; showed 3 positive samples for a percentage of 2.14% ( Fig. 2A , Table S1 ).

The qPCR test revealed the presence of SARS-CoV-2 RNA in 16 of the 133 samples of the mother"s nasopharyngeal swabs (12.03%) ( Fig. 2A , Table S1 ).

Further exploration of the presence of the viral RNA by digital droplet PCR (ddPCR), confirmed the positive qPCR results and unveiled the existence of 25 more samples for a total of 41 (30.83%) (Fig. 2B , Table S2 ). For the case of SARS-CoV-2 RNA presence in the neonate nasopharyngeal swabs determined by qPCR, the percentage was 8.40% (11 samples of 131) ( Fig. 2A, Table S1 ). Further retesting of these samples using ddPCR analysis, confirmed the 11 positive qPCR results, and unveiled the existence of 13 more positive samples for a total of 24 positive among the 131 collected neonate nasopharyngeal swabs. This indicated a vertical transmission of approximately 18.32% (Fig. 2B, Table S2 ) A similar situation occurred for the positivity in the 140 human colostrum/milk collected from asymptomatic mothers within the 48h immediately after delivery and before feeding the newborns; where it increased from 2.14% by qPCR (3 of 140) ( Fig. 2A , Table   S1 ) to 14.29% (20 of 140) by ddPCR (Fig. 2B , Table S2 ).

The persistence of COVID-19 pandemic in the world demands continuous study of the nature of this disease from all scientific areas of expertise. One important aspect of this malady is the mode and frequency of transmission, mostly in vulnerable members of the population like pregnant women. The mother-neonate pairs represent an excellent opportunity to assess the frequency of the SARS-CoV-2 virus vertical transmission, since normally, the binomial link involves intimate contact as well as neonates feeding with human milk.

Our results with the 133 mothers of our sample, suggest that in the Mexican population, 1 of 8 asymptomatic pregnant women (12.03%), 23-24 years old, with a 38 to 39 weeks gestational age, were positive for the presence of the SARS-CoV-2 genome in the nasopharyngeal swabs taken just before delivery. The frequency showed in our population seems to be greater compared with other countries sampled at the same period in the first COVID-19 wave. The results obtained in a UK cohort, estimated the incidence of positivity for SARS-CoV-2 in asymptomatic pregnant women was 1.2 per 1000 maternities (~0.12%) from March to September of 2020 (Vousden et al., 2021) ; in addition, during April 2020 one study made by the Mass General Brigham Health system in Boston found that 9 of 618 (1.5%) asymptomatic mothers tested positive (Goldfarb et al., 2020) . However, our results are comparable to another study made from April 4th to 15th, 2020, in Mount Sinai

Health system in New York City, where 24 of 155 (15.5%) COVID-19 asymptomatic mothers tested positive for SARS-CoV-2 RNA (Bianco et al., 2020) .

The same test performed in the nasopharyngeal swabs collected from the 131 neonates immediately after delivery showed that approximately 1 of ~12 (~8.40%) were positive for the presence of the SARS-CoV-2 genome. Likewise in a study in Indian population 12 of 155 neonates (7.74%) tested positive for SARS CoV-2 infection (Kalamdani et al., 2020) . It is important to remark that in our study, none of the neonates had been breastfed by their mother before samples were taken. This support the notion that the possibility of vertical transfer of the virus through breast feeding or mother"s handling was not possible. However, as mentioned above, we observed a frequency of 11 of 131 (~8.40%) positive nasopharyngeal swabs.

The source of the SARS-Cov-2 RNA in the neonates, might be the transmission from the placenta. For example, there are some published evidences in this sense: there is a report that SARS-CoV-2 virus spread in the body of an Italian pregnant women through the bloodstream, reaching the placenta and finally infecting the fetus (Fenizia et al., 2020) ; the birth of Chinese neonates of mothers with COVID-19 pneumonia (Zhu et al., 2020) ; the evidence of vertical transition of SARS-CoV-2 to one neonate in an Iranian mother (Zamaniyan et al., 2020) ; or the report of SARS-CoV-2 RNA presence in the placenta in two Italian mothers and neonates at birth (Patanè et al., 2020) . In addition, our work provides evidence of SARS-CoV-2 virus vertical transmission from mothers to neonates, which might help to answer valid questioning about the absence of evidence (Auriti et al., 2020) .

Contrary to the results in other reports, in our work there was not an association of the neonate"s data collected at birth by the pediatrician (somatometry, sex and newborn qualification status) with the positive result by qPCR, and any collected metadata of the mothers as reported in other populations like British healthy pregnant women, where the positivity to SARS-CoV-2 was associated to preterm neonates, and cesarean section delivery (Vousden et al., 2021) , or Turkish healthy pregnant women where the positivity was associated to cesarean section, prematurity and low birth weight (Oncel et al., 2021) .

All the 140 studied mothers expressed a sample of colostrum or milk to be studied. It was observed that most samples were negative for the presence of the SARS-CoV-2 genome by qPCR test ( The results obtained in this study strongly suggest that in the Mexican population, asymptomatic women carried the SARS-CoV-2 virus during delivery, with perinatal transmission of SARS-CoV-2 virus to the newborns. However, since the presence of the SARS-CoV-2 RNA in colostrum/milk was comparatively minor, and sampling was immediately after birth, the detection of positive neonates might be due to infection by the virus in-utero.

We re-assayed most of the nasopharyngeal swabs and colostrum/milk samples by droplet digital PCR; finding that this more sensitive technique increased the percentage of positive samples approximately 2.6-fold for nasopharyngeal swabs of mothers, 6.7-fold for colostrum/milk and 2.2-fold for the nasopharyngeal neonate swabs ( Fig. 2A, 2B , Tables S1, S2).

In terms of the scope of our work, there are limitations like the sample size and the need to expand the studies, sampling not only nasopharyngeal swabs in mothers-neonates as well as colostrum/human milk, but also collecting other important samples like amniotic fluid, umbilical cord blood, and peripheral blood from the binomials, which are informative to evaluate the presence of the SARS-CoV-2 genome during delivery. In addition, our conclusions may not be generalized to other populations.

This work was financed by Secretaría de Relaciones Exteriores México (SRE), No.

Desarrollo (AMEXCID), No. AMEXCID 2020-5.

The study was approved by the Bioethics Committee in Research of the General Hospital "Dr. Gustavo Baz Prada" with the registry 2 8C 5 T-3157_2020-08, and all participants signed informed consent in accordance with the Declaration of Helsinki.

The authors declare no conflicts of interest. Complications during delivery Fetal suffering 1 (9.09%) 1 (0.95%) -Perinatal asphyxiation 0 (0.0%) 2 (1.80%) -Breathing difficulty 0 (0.0%) 1 (0.95%) -Infection 0 (0.0%) 1 (0.95%) -Sepsis 0 (0.0%) 0 (0.0%) -Death 0 (0.0%) 0 (0.0%) -IUGR, Intrauterine growth restriction. *Mann-Whitney U test, significant p value < 0.05. Standard deviation is shown as ± values between parentheses. -, no value was calculated for categorical data. λ estimated gestational age in weeks (Engle WA, 2004) . κ respiratory severity score Hedstrom et al., 2 8 . β= of 5 subjects, π= 5 subjects, ζ= of 4 subjects, μ= 4 subjects, ε= 3 subjects.

Vertical Transmission of SARS-CoV-2 (COVID-19): Are Hypotheses More than Evidences?

Placental Pathology in Covid-19 Positive Mothers: Preliminary Findings

Human Breast Milk-acquired Cytomegalovirus Infection: Certainties, Doubts and Perspectives

Breast Milk and COVID-19: From Conventional Data to

Positive Mothers

Infection Before Scheduled Deliveries

SARS-CoV-2 infection in children: Transmission dynamics and clinical characteristics

Pre-labor anorectal swab for SARS-CoV-2 in COVID-19 pregnant patients: is it time to think about it?

Transmission of SARS-CoV-2 through breast milk and breastfeeding: a living systematic review

CDC -Center for Disease Control and Prevention

Tablero México -CONACYT -CentroGeo -GeoInt -DataLab c2021

Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR

Vertical transmission of SARS CoV-2: a systematic review

Analysis of SARS-CoV-2 vertical transmission during pregnancy

Relationship between pregnancy and coronavirus: what we know

Universal SARS-CoV-2 testing on admission to the labor and delivery unit: Low prevalence among asymptomatic obstetric patients

Performance of the Silverman Andersen Respiratory Severity Score in predicting PCO2 and respiratory support in newborns: a prospective cohort study

SARS-CoV-2 infection of the placenta

Clinical Profile of SARS-CoV-2 Infected Neonates From a Tertiary Government Hospital in Mumbai

Vertical Transmission of Coronavirus Disease 19 (COVID-19) from Infected Pregnant Mothers to Neonates: A Review

SARS-CoV-2 and human milk: What is the evidence?

Asymptomatic COVID-19 infection in late pregnancy indicated no vertical transmission

A controversial debate: vertical transmission of COVID-19 in pregnancy

Neonatal Intensive Care Unit-Specific Lactation Support and Mother's Own Breast Milk Availability for Very Low Birth-Weight Infants

A multicenter study on epidemiological and clinical characteristics of 125 newborns born to women infected with COVID-19 by Turkish Neonatal Society

Characterization of SARS-CoV-2 RNA, Antibodies, and Neutralizing Capacity in Milk Produced by Women with COVID-19. mBio

Vertical transmission of coronavirus disease 2019: severe acute respiratory syndrome coronavirus 2 RNA on the fetal side of the placenta in pregnancies with coronavirus disease 2019-positive mothers and neonates at birth

Transmission of SARS-CoV-2: an update of current literature

Coronavirus Infections-More Than Just the Common Cold

SARS-CoV-2 and the role of vertical transmission from infected pregnant women to their fetuses: systematic review. medRxiv

What are the risks of COVID-19 infection in pregnant women?

Managing COVID-19-Positive Maternal-Infant Dyads: An Italian Experience

Lineamiento Estadarizado Para la Vigilancia Epidemiológica y por Laboratorio de Covid-19

Epidemiología de COVID-19 en México: del 27 de febrero al 30 de abril de 2020 [Epidemiology of COVID-19 in Mexico: from the 27th of February to the 30th of

Breastfeeding and COVID-19: From Nutrition to Immunity

The incidence, characteristics and outcomes of pregnant women hospitalized with symptomatic and asymptomatic SARS-CoV-2 infection in the UK from

A novel coronavirus outbreak of global health concern

WHO -World Health Organization

Global Strategy for Infant and Young Child Feeding

pdf;sequenc e=1 WHO -World Health Organization [Internet] WHO Coronavirus (COVID-19) c2021

The SARS-CoV-2 outbreak: What we know

Vertical Transmission of Severe Acute Respiratory Syndrome Coronavirus 2: A Systematic Review

Preterm delivery, maternal death, and vertical transmission in a pregnant woman with COVID-19 infection

Single-cell RNA expression profiling of ACE2 and AXL in the human maternal-Fetal interface. Reproductive and Developmental Medicine

Clinical analysis of 10 neonates born to mothers with 2019-nCoV pneumonia. Translational pediatrics

vertical shaded area), equivalent to the reported week commencing 21 to 34 (x-axis). The estimated cases are plotted using solid cherry color line (left y-axis), and the confirmed deaths using dashed black color line (right y-axis)

A: Quantitative PCR detection, positive results for M are 12.03%; C, 2.14%, and N, 8.40%. B: Digital PCR detection

/human milk samples (n = 140), and N, neonate nasopharyngeal swab (n = 131). For N, results contain data for three additional samples with incomplete data for qualification status, somatometry, and complications during delivery

We are grateful to all mothers who participated in the study, to Carolina Miranda-Brito for technical support in data curation, and Viridiana Rosas Ocegueda for administrative assistance. PZ-S (43142), FB-G (225525), and JG-M (19815) are Fellows from the Sistema Nacional de Investigadores, Mexico. PZ-S is also a EDI-IPN and COFAA-IPN fellow.